Transferrin receptors associate with drug resistance in cancer cells.

Biochem Biophys Res Commun

Center for Reproduction and Transplantation Immunology, Methodist Hospital of Indiana, Indianapolis 46202.

Published: December 1993

AI Article Synopsis

Article Abstract

Transferrin mediates its growth promoting properties through transferrin receptors, which are increased on cancer cells. We have studied drug-sensitive and drug-resistant cancer cells by using quantitative flow cytomerty with fluorochrome labelled transferrin and antibody to transferrin receptor, and we have found that drug-resistant cells have more transferrin receptors than drug-sensitive cells. This finding was confirmed and extended by using isotopically labelled ligand and by correcting for differences in cell surface areas. We also found that the number of transferrin receptors could be down-regulated by calcium channel blockers, and that such down-regulation diminished drug resistance, suggesting a hitherto unrecognised role for transferrin receptors in drug resistance.

Download full-text PDF

Source
http://dx.doi.org/10.1006/bbrc.1993.2536DOI Listing

Publication Analysis

Top Keywords

transferrin receptors
20
drug resistance
12
cancer cells
12
transferrin
8
cells transferrin
8
cells
5
receptors associate
4
associate drug
4
resistance cancer
4
transferrin mediates
4

Similar Publications

Aplastic Anemia (AA) is one of the life-threatening bone marrow failure syndromes. One of the main pathologies of AA is reduced erythropoietic activity evidenced by decreased soluble transferrin receptor (sTfR) levels which results in minimal iron utilization and accumulation of iron in tissues in the form of ferritin. This study aimed to measure serum level of sTfR in adult AA patients and correlate it with the severity of the disease and the response to treatment.

View Article and Find Full Text PDF

Targeted Delivery of BMS-1166 for Enhanced Breast Cancer Immunotherapy.

Int J Nanomedicine

January 2025

College of Science, Mathematics and Technology, Wenzhou-Kean University, Wenzhou, Zhejiang, People's Republic of China.

Background: Cancer immunotherapy has achieved great success in breast cancer treatment in recent years. The Programmed Death-1 (PD-1) /Programmed Death-Ligand 1 (PD-L1) immune checkpoint pathway is among the most studied. BMS-1166, a PD-L1 inhibitor, can interfere with PD-1 and PD-L1 interaction.

View Article and Find Full Text PDF

MSC-EXs inhibits uranium nephrotoxicity by competitively binding key proteins and inhibiting ROS production.

Ecotoxicol Environ Saf

January 2025

Institute of Combined Injury, State Key Laboratory of Trauma and Chemical Poisoning, Military Key Laboratory of Nanomedicine, Department of Military Preventive Medicine, Army Medical University, Chongqing 400038, China. Electronic address:

Uranium poisoning, particularly from exposure to Depleted Uranium (DU), occurs when uranyl ions enter the bloodstream and bind primarily to transferrin, osteopontin, and albumin before entering cells via corresponding receptors on renal tubular membranes, leading to cellular damage. Uranium poisoning remains a significant clinical challenge, with no ideal treatment currently available. In this study, we investigate the therapeutic potential of human umbilical cord-derived mesenchymal stem cell exosomes (MSC-EXs) in mice exposed to DU.

View Article and Find Full Text PDF

Tamoxifen is an inhibitor of estrogen receptors and was originally developed for breast cancer therapy. Besides, tamoxifen is widely used for Cre-estrogen receptor-mediated conditional knockout in transgenic mice. However, we found that the 3-month feeding of 0.

View Article and Find Full Text PDF

How prevalent are lactoferrin receptors in Gram-negative bacteria?

Biochem Cell Biol

January 2025

Department of Microbiology, Immunology, and Infectious Diseases, Snyder Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Surface receptors in Gram-negative bacteria that bind and extract iron from the host glycoproteins transferrin (Tf) or lactoferrin (Lf) was discovered 35 years ago in pathogenic species and subsequently was discovered in other pathogens of humans and food production animals. These bacterial species reside exclusively on the mucosal surfaces of the respiratory or genitourinary tract of their mammalian host and rely on their host specific Tf and Lf receptors to acquire iron for survival. Since the specificity of the bacterial Tf receptors was shown to be due to selective pressures on the host Tf, their presence in bacteria that reside in both mammals and birds indicates that they arose over 320 million years ago.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!